Pharmacodynamic Study of 100mg Suzegtrigine vs Placebo in Healthy Male Adults

Suzetrigine is an inhibitor of the NaV1.8 voltage-gated sodium channel and FDA approved for the treatment of moderate-to-severe acute pain in adults

biologically inactive placebo comparator